Sterling Capital Management’s Tango Therapeutics TNGX Stock Holding History

Sterling Capital Management’s Portfolio TNGX Stock Details TNGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$15.5K	Sell	495 -3,185	-87%	-$78.7K	﹤0.01%	2003
2026 Q1	$77K	Sell	3,680 -2,450	-40%	-$34.1K	﹤0.01%	1481
2025 Q4	$54.3K	Buy	6,130 +1,180	+24%	+$10.2K	﹤0.01%	1773
2025 Q3	$41.6K	Buy	4,950 +2,879	+139%	+$19.5K	﹤0.01%	1821
2025 Q2	$10.6K	Buy	2,071 +2,022	+4,127%	+$5K	﹤0.01%	2096
2025 Q1	$67	Hold	49	–	–	﹤0.01%	3168
2024 Q4	$151	Hold	49	–	–	﹤0.01%	3146
2024 Q3	$377	Buy	+49	New	+$468	﹤0.01%	2974

Other funds holding TNGX

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return

Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

CUAMC

China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

DACS

Dymon Asia Capital (Singapore) Singapore $2.39B AUM 150.5% 1-Year Est. Return

PSP Research Newtown Square, Pennsylvania $188M AUM

Caprock Group Boise, Idaho $5.22B AUM 42.47% 1-Year Est. Return

Sterling Capital Management's TNGX Position: Q2 2026 in Review

Sterling Capital Management reduced its Tango Therapeutics (TNGX) stake by 87% in Q2 2026, selling an estimated $78.7K and leaving 495 shares worth $15.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2003.

Sterling Capital Management first reported a position in TNGX in Q3 2024 and has held it in 8 quarters since. The position peaked at $77K in Q1 2026. 24 funds tracked by Wall St. Rank hold TNGX as of Q2 2026.

Sterling Capital Management held 495 shares of Tango Therapeutics worth $15.5K as of Q2 2026.
Sterling Capital Management sold 3,185 Tango Therapeutics shares in Q2 2026, an estimated $78.7K.
Tango Therapeutics made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #2003 holding.
Sterling Capital Management first reported a position in Tango Therapeutics in Q3 2024 and has held it in 8 quarters since.
Sterling Capital Management's Tango Therapeutics position peaked at $77K in Q1 2026.
24 funds tracked by Wall St. Rank held Tango Therapeutics as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.